Bama Biotech, Inc. – Stock Purchase Agreement Dated as of April 5, 2012 by and Among Shuairui Qiu and Amit Tandon and Ajay Tandon and Emerging Growth Acquisitions I, Inc. (April 9th, 2012)
This stock purchase agreement ("Agreement"), dated as of April 5, 2012, is entered into by and among Emerging Growth Acquisitions I, Inc. ("Emerging Growth Acquisition" or the "Company") and Amit Tandon and Ajay Tandon (each a "Seller" and collectively, the "Sellers"), and Shuairui Qiu (the "Purchaser" and together with the Company and the Sellers, the "Parties").
Bama Biotech, Inc. – Description of Verbal Management Consulting Agreement Between Emerging Growth Acquisitions I, Inc. And Amit Tandon (September 24th, 2010)
On July 30, 2010, Mr. Tandon, the President and sole director of the Company, verbally agreed to provide funding to cover the costs of investigating and analyzing business combinations for the next 12 months and beyond, until the Company is engaged in business activities that provide cash flow sufficient to cover the costs of investigating and analyzing business combinations. We currently have no written contractual agreements in place with Mr. Tandon to provide such funding. During the next 12 months, Mr. Tandon has agreed to cover costs including, but not limited to, the filing of Exchange Act reports, and consummating an acquisition. At this time we do not have the funds to pay for these filings and do not have any written agreement to raise funds to cover these expenses. However, we believe we will be able to meet these costs with funds provided by Mr. Tandon. At such time that the Company has the ability to cover the costs of investigating and analyzing business combinations with